In the BioHarmony Drug Report Database

"Preview" Icon

Fexofenadine

Allegra, Allegra Hives, Children’s Allegra, Children’s Allegra Hives (fexofenadine) is a small molecule pharmaceutical. Fexofenadine was first approved as Allegra on 1996-07-25. It is used to treat allergic rhinitis perennial and urticaria in the USA. The pharmaceutical is active against histamine H1 receptor. Fexofenadine hydrochloride’s patents are valid until 2030-08-02 (FDA).

 

Trade Name

 

Allegra, Allegra Hives, Children's Allegra, Children's Allegra Hives
 

Common Name

 

fexofenadine
 

ChEMBL ID

 

CHEMBL914
 

Indication

 

allergic rhinitis perennial, urticaria
 

Drug Class

 

Image (chem structure or protein)

Fexofenadine structure rendering